A Phase 1, Randomized, Double-blind, Third-party Open, Placebo-controlled Study To Evaluate The Safety, Tolerability, And Pharmacokinetics After Multiple Oral Doses Of Pf-06700841 In Healthy Japanese Subjects

Trial Profile

A Phase 1, Randomized, Double-blind, Third-party Open, Placebo-controlled Study To Evaluate The Safety, Tolerability, And Pharmacokinetics After Multiple Oral Doses Of Pf-06700841 In Healthy Japanese Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Oct 2017

At a glance

  • Drugs PF 6700841 (Primary)
  • Indications Alopecia areata; Plaque psoriasis; Ulcerative colitis
  • Focus Adverse reactions
  • Sponsors Pfizer
  • Most Recent Events

    • 23 Oct 2017 Status changed from recruiting to completed.
    • 25 Sep 2017 Planned End Date changed from 13 Oct 2017 to 12 Oct 2017.
    • 04 Sep 2017 Planned End Date changed from 12 Oct 2017 to 13 Oct 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top